BRAIN Biotech AG (FRA:BNN)

BRAIN Biotech AG Statistics

Total Valuation

FRA:BNN has a market cap or net worth of EUR 50.69 million. The enterprise value is 65.10 million.

Market Cap	50.69M
Enterprise Value	65.10M

Important Dates

The last earnings date was Wednesday, January 14, 2026.

Earnings Date	Jan 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	21.85M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	11.67%
Float	15.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.01
PB Ratio	27.55
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.54
EV / Sales	1.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.05

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 11.27.

Current Ratio	1.42
Quick Ratio	0.86
Debt / Equity	11.27
Debt / EBITDA	n/a
Debt / FCF	-1.93
Interest Coverage	-3.52

Financial Efficiency

Return on equity (ROE) is -150.49% and return on invested capital (ROIC) is -15.45%.

Return on Equity (ROE)	-150.49%
Return on Assets (ROA)	-6.25%
Return on Invested Capital (ROIC)	-15.45%
Return on Capital Employed (ROCE)	-15.91%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	171,973
Profits Per Employee	-40,212
Employee Count	292
Asset Turnover	0.65
Inventory Turnover	2.41

Taxes

Income Tax	-191,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.40% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.40%
50-Day Moving Average	2.74
200-Day Moving Average	2.27
Relative Strength Index (RSI)	39.50
Average Volume (20 Days)	965

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:BNN had revenue of EUR 50.22 million and -11.74 million in losses. Loss per share was -0.54.

Revenue	50.22M
Gross Profit	28.10M
Operating Income	-7.76M
Pretax Income	-12.02M
Net Income	-11.74M
EBITDA	-4.35M
EBIT	-7.76M
Loss Per Share	-0.54

Balance Sheet

The company has 6.32 million in cash and 20.73 million in debt, with a net cash position of -14.42 million.

Cash & Cash Equivalents	6.32M
Total Debt	20.73M
Net Cash	-14.42M
Net Cash Per Share	n/a
Equity (Book Value)	1.84M
Book Value Per Share	0.08
Working Capital	7.36M

Cash Flow

In the last 12 months, operating cash flow was -9.23 million and capital expenditures -1.53 million, giving a free cash flow of -10.77 million.

Operating Cash Flow	-9.23M
Capital Expenditures	-1.53M
Free Cash Flow	-10.77M
FCF Per Share	n/a

Margins

Gross margin is 55.95%, with operating and profit margins of -15.45% and -23.38%.

Gross Margin	55.95%
Operating Margin	-15.45%
Pretax Margin	-23.94%
Profit Margin	-23.38%
EBITDA Margin	-8.67%
EBIT Margin	-15.45%
FCF Margin	n/a

Dividends & Yields

FRA:BNN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-23.17%
FCF Yield	-21.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:BNN has an Altman Z-Score of -1.43 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.43
Piotroski F-Score	3